News

Press ReleaseINmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readiness
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Regulatory Round-up - March 2025Regulatory Round-up - March 2025Regulatory Round-up - February 2025Regulatory Round-up - February 2025Network established to identify opportunities for regulation to support innovation within advanced therapiesNetwork established to identify opportunities for regulation to support innovation within advanced therapiesRegulatory Round-up - January 2025Regulatory Round-up - January 202570% increase in Phase I advanced therapy clinical trials in the UK in 202470% increase in Phase I advanced therapy clinical trials in the UK in 2024Regulatory Round-up - December 2024Regulatory Round-up - December 2024Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingRegulatory Round-up - November 2024Regulatory Round-up - November 2024Cell and gene therapy industry continues to expand manufacturing infrastructure in the UKCell and gene therapy industry continues to expand manufacturing infrastructure in the UKRegulatory Round-up - October 2024Regulatory Round-up - October 2024100 apprenticeships completed through the Advanced Therapies Apprenticeship Community100 apprenticeships completed through the Advanced Therapies Apprenticeship CommunityCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapiesCGT Catapult, Pharmaron Biologics (UK) Ltd and Complement Therapeutics receive £1.4m grant to develop a perfusion process to improve production of gene therapies